This opening session brings together pharmacy executives from IDNs and national GPOs for a highly interactive, peer-driven discussion focused on introductions and recent organizational achievements. Participants will have the opportunity to share key initiatives, strategic wins, and areas of focus within their pharmacy enterprise, while engaging in open conversation with peers facing similar operational and financial challenges. The session is designed to surface practical insights through dialogue rather than presentation, with an emphasis on shared learning across executive leaders.

Join fellow pharmacy executives in a conversational forum where peer exchange and facilitated discussion set the foundation for the remainder of the program.

Learning Objectives:
1. Recognize current strategic initiatives and priorities across peer pharmacy organizations. 
2. Compare recent achievements and operational approaches among IDN and GPO pharmacy leaders. 
3. Identify common themes and challenges emerging from peer discussion. 
4. Engage in collaborative dialogue to surface shared insights and lessons learned.

Drug shortages continue to present significant operational, clinical, and financial challenges for pharmacy leaders, requiring real-time coordination, escalation protocols, and cross-functional alignment across the enterprise. This highly interactive session will focus on how IDNs are responding to ongoing and emerging shortages, including mitigation strategies, communication frameworks, and approaches to maintaining continuity of care. Rather than a formal presentation, the session is structured as an open, facilitated discussion with active participation from all attendees.

Join pharmacy executives in a peer-to-peer dialogue led by a senior facilitator, designed to surface real-world strategies and shared experiences in managing drug shortages.

Learning Objectives:
1. Identify key drivers and patterns contributing to ongoing drug shortages across the pharmaceutical supply chain. 
2. Analyze operational and clinical strategies used by IDNs to mitigate shortage impacts. 
3. Evaluate communication and escalation frameworks that support effective shortage management. 
4. Share peer-based approaches for maintaining continuity of care during supply disruptions.

Across many IDNs, 340B is no longer being discussed solely in terms of compliance or financial contribution, but increasingly as a strategic decision point in broader pharmacy and enterprise planning. This session brings pharmacy executives together to discuss how leadership teams are approaching the future of their 340B programs, whether through expansion, restructuring, diversification of reliance, or reevaluation of program role within overall pharmacy strategy. The conversation will focus on how executives are thinking beyond day-to-day management and into longer-term positioning, trade-offs, and organizational intent.

Join pharmacy peers in a discussion focused on strategic decision-making frameworks and how systems are rethinking the future role of 340B within pharmacy enterprise strategy.

Learning Objectives:
1. Examine how IDNs are reassessing the strategic role of 340B within pharmacy operations. 
2. Identify different approaches to long-term program positioning, dependence, or diversification. 
3. Discuss how executive teams are incorporating 340B into broader enterprise planning decisions. 
4. Compare peer perspectives on future-oriented 340B strategy and structural choices.